SPECIFIC DIAGNOSTICS Mountain View, CA, USA
SPECIFAST (renamed REVEAL™ AST)
AST & ID WITHIN HOURS OF POSITIVE BLOOD CULTURE
Specific’s AST instrument identifies antimicrobial susceptibility in 4 hours, directly from positive blood culture samples. Printed, disposable sensor arrays positioned over each well of a 96-well antibiotic plate rapidly and sensitively detect the emitted volatile molecules that are the first sign of bacterial growth, enabling the fastest reported phenotypic determination of susceptibility in the urgent and time-sensitive case of antimicrobial-resistant bloodstream infection. The simplicity, high throughput, and relatively low cost of this system suits it for wide adoption.
Current Development Stage: Product Development
CARB-X Investment: Initial investment of up to $1.7m with potential option payments up to $1.7m.
Initial CARB-X Investment Date: March 1, 2018